Koninklijke Philips N.V. (PHG) Fair Value 2026

PHG · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.1 /10

32 fundamental signals · 10 models active

Value Trap Risk

LOW (29/100)

Quick Summary — As of 2026-08-28, Koninklijke Philips N.V. (PHG) trades at $26.72, versus a $25.39 median fair value across its 10 active models — 5.0% below the current price. QOC: 7.1/10. Value Trap Risk: 29/100 (LOW). 10/13 models active. Within that set, the Bayesian DCF component alone returns $29.98.

Key Facts

Ticker
PHG
Price
$26.72
Quality Score
7.1/10
Value Trap Risk
29/100
Models Active
10/13
Last Updated
Strength: Bayesian DCF suggests +12.2% upside with 63% confidence
Risk: Majority of models suggest overvaluation

Is Koninklijke Philips N.V. (PHG) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Koninklijke Philips N.V. (PHG) appears fairly valued as of : the median of 10 independent fair value estimates is $25.39, within 5.0% of the current price of $26.72. Estimates range from $5.54 to $49.35. PHG scores 7.1/10 on fundamental quality and 29/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. PHG’s -5.0% gap is narrower than that market norm, and the Medical Devices sector median is -43.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Koninklijke Philips N.V. Stock in 2026? →

What Fair Value Does Each Model Give PHG?

10 Intrinsic Value Models vs. Current Price ($26.72)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $29.98 +12.2%
Intrinsic · High Conviction
 $5.54 -79.3%
Ensemble · Low Conviction
 $24.03 -10.1%
Intrinsic · High Conviction
 $22.38 -16.3%
Unlock the Full Matrix

Access 6 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is PHG's Fair Value Range?

Spread across 10 independent models · $5.54 to $49.35

CirclFi's 10 active models place Koninklijke Philips N.V. (PHG) between $5.54 and $49.35 per share, a spread of 173% of the median. The median of that range — $25.39 — is the fair value CirclFi publishes for PHG, against a current price of $26.72.

Low · EPVHigh · Regime Cross
$5.54median $25.39$49.35
Where the range comes from
Most bearish modelEarnings Power Value (EPV)$5.54
Most bullish modelRegime Cross-Sectional$49.35
Model agreement4 bullish · 5 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for PHG. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on PHG, not a CirclFi price target. How each model works →

What Is Koninklijke Philips N.V. (PHG) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Koninklijke Philips N.V.'s intrinsic value is estimated at $25.39, presenting a divided outlook at the current price of $26.72. With a median implied return of -5.0% across a split 4–5 (bull–bear) consensus, the model spread of +164.0% underscores analytical uncertainty. Notably, Regime Cross sees the most upside at +84.7% (fair value: $49.35), while EPV is the most conservative at -79.3% ($5.54). The spread between these extremes — +164.0% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About PHG?

10 of 13 models are currently active for PHG. Of these, 5 models suggest upside while 5 models suggest overvaluation. Taken together, their median fair value for PHG is $25.39 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $29.98 on its own, implying +12.2% upside from the current price. See which stocks rank higher →

How Does PHG Rank in Medical Devices?

Among 159 Medical Devices stocks, PHG ranks #44 by Quality of Company score. CirclFi's QOC score of 7.1/10 evaluates 32 fundamental signals. A score of 7.1 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

Within the Medical Devices space, Koninklijke Philips N.V. competes in an environment where R&D productivity ratio often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is PHG a Value Trap?

CirclFi's Value Trap algorithm assigns PHG a score of 29/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Koninklijke Philips N.V.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Koninklijke Philips N.V.'s fundamental quality profile registers 7.1/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +164.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every PHG valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across PHG's 10 active models, average confidence is 49%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Koninklijke Philips N.V. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

IARTIntegra LifeSciences Holdings CorporationQOC 7.1KIDSOrthoPediatrics Corp.QOC 7.1LUNGPulmonx CorporationQOC 7.2NVCRNovoCure LimitedQOC 7.1AORTArtivion, Inc.QOC 7.3LNSRLENSAR, Inc.QOC 7.1NSPRInspireMD, Inc.QOC 6.1IVFINVO Fertility, Inc.QOC 5.1DXCMDexCom, Inc.QOC 9.2IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: IART · KIDS · LUNG · NVCR · AORT · LNSR · NSPR · IVF · DXCM · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to PHG?

7 companies across all industries closest to PHG’s Quality of Company score of 7.1/10.

LGLThe LGL Group, Inc.QOC 7.1AMTMAmentum Holdings, Inc.QOC 7.1BRLTBrilliant Earth Group, Inc.QOC 7.1KNFKnife River CorporationQOC 7.1RBLXRoblox CorporationQOC 7.1STSensata Technologies Holding plcQOC 7.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: LGL · AMTM · BRLT · KNF · RBLX · ST · NVDA

Where Does PHG Sit in CirclFi's Medical Devices Rankings?

PHG is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Koninklijke Philips N.V.’s Valuation?

What is Koninklijke Philips N.V.'s intrinsic value in 2026?

CirclFi puts Koninklijke Philips N.V. (PHG)'s intrinsic value at $25.39 — the median of 10 independent model estimates as of 2026-08-28, ranging from $5.54 to $49.35. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $29.98 on its own. The Quality of Company score is 7.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is PHG overvalued or undervalued right now?

At $26.72, 5 of 10 active models suggest PHG may be undervalued, while 5 indicate potential overvaluation. The median of all 10 fair value estimates is $25.39, within 5.0% of the current price of $26.72 — a consensus view that PHG is fairly valued. The assessment depends on which methodology best fits Koninklijke Philips N.V.'s business model in Medical Devices.

What does a Quality of Company score of 7.1 mean for PHG?

Koninklijke Philips N.V.'s QOC of 7.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on PHG?

CirclFi analyzes PHG with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on PHG?

Of the 10 models currently active on PHG, Regime Cross-Sectional is the most bullish at $49.35 per share, and Earnings Power Value (EPV) is the most bearish at $5.54. CirclFi's published fair value for PHG is the median of that range, $25.39, not either extreme. The gap between the two ends equals 173% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is PHG a value trap in 2026?

Koninklijke Philips N.V.'s Value Trap score is 29/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Koninklijke Philips N.V. (PHG) has a median fair value of $25.39 — within 5.0% of the current price of $26.72 — as of 2026-08-28.” Source: circlfi.com/stock/PHG/ · Methodology
Primary sources for this PHG valuation
  • Financial statements: Koninklijke Philips N.V. 10-K and 10-Q filings on SEC EDGAR (CIK 0000313216) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for PHG as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on PHG.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

6 models hidden for PHG Unlock All 10 — $39/mo